Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects of Posiphen in Subjects With Early Alzheimer's Disease (AD)

Next Previous
X
Search
Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects of Posiphen in Subjects With Early Alzheimer's Disease (AD)

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Buntanetap (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Acronyms DISCOVER
  • Sponsors Annovis Bio

    • Most Recent Events

    • 01 Apr 2024 Results that supports understanding of Buntanetaps mechanism of action in humans presented in the Annovis Bio Media Release.
    • 18 Jul 2023 According to an Annovis Bio media release, data from this trial was presented in a posters presentation by Don Elbert, Ph.D., at the Alzheimer's Association International Conference (AAIC) 2023 annual meeting held in Amsterdam, Netherlands, from July 16 - 20.
    • 11 May 2023 According to an Annovis Bio media release, data from this study was presented at the AD/PD™ 2023 International Conference on Alzheimer's and Parkinson's Diseases.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top